Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke
MAASP
1 other identifier
observational
28
1 country
1
Brief Summary
Stroke is one of main causes of death and impairment worldwide. Objective of this study is to analyze serum High Sensitivity C-Reactive Protein in acute phase stroke in patients attended at Petróleos Mexicanos Hospital Central Sur de Alta Especialidad and to correlate with stroke extension and clinical features.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 4, 2014
CompletedFirst Posted
Study publicly available on registry
June 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedJune 24, 2014
June 1, 2014
1.6 years
June 4, 2014
June 21, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measure of serum High sensitivity C-Reactive Protein level
Serum levels of serum High sensitivity C-Reactive Protein will be measured in patients with suspicion of stroke at the emergency room within the first 8 hours of arrival at our hospital
within the first 8 hours since admission to hospital
Secondary Outcomes (1)
National Institutes of Health Stroke Scale
within the first 4 hours since admission to emergency room
Other Outcomes (3)
Stroke extension
within the first 4 hours since admission to emergency room
Origin of stroke
origin will be diagnosed during the hospital stay expecting no more than 1 week
Hospital stay
hospital stay is expected for no more than 1 week unless intensive care unit is needed
Study Arms (1)
stroke
Patients admitted to hospital who are diagnosed with stroke will be treated as usually a our center by observation, venous or arterial thrombolysis depending on extension, condition, thrombolysis feasibility.
Eligibility Criteria
Patients affiliated to Petróleos Mexicanos medical system of any gender between 18 and 80 years old suspected of acute phase stroke who arrive to emergency room at our hospital
You may qualify if:
- Patients suspected of acute phase stroke who arrive to emergency room at our hospital
- Patients affiliated to Petróleos Mexicanos medical system
- Patients of any gender
- Patients between 18 and 80 years old
You may not qualify if:
- Stroke provoked by angiographic procedure
- Pregnancy
- Patient under chemotherapy or radiotherapy
- Recently surgery or trauma among last 30 days
- Heparin usage
- Stroke and/ or thrombolysis history
- Active infection
- Liver disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Central Sur Alta Especialidad
Mexico City, Tlalpan, 14140, Mexico
Biospecimen
serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Md
Study Record Dates
First Submitted
June 4, 2014
First Posted
June 24, 2014
Study Start
June 1, 2013
Primary Completion
January 1, 2015
Last Updated
June 24, 2014
Record last verified: 2014-06